CURE Pharmaceutical CBD Oral Thin Film Pharmacokinetic Study Shows Improved Bioavailability Compared to CBD Soft Gel
July 15, 2020 08:00 ET
|
CURE Pharmaceutical Holding Corp.
OXNARD, Calif., July 15, 2020 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced that its 25mg cannabidiol (CBD) oral thin film...
Parallax Diagnostics Partners with CURE Pharmaceuticals to Distribute Individually Sealed CUREfilm® D for Medical and Critical Services Workers
April 07, 2020 10:21 ET
|
Parallax Health Sciences, Inc.
COVID-19 Coronavirus Infection Risk May be Reduced by Weekly Dose of Vitamin D3 NEW YORK, NY, April 07, 2020 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Parallax Health Sciences, Inc. (OTCQB:...
CURE Pharmaceutical [OTCQB:CURR] and Canopy Growth to Produce CBD Oral Thin Films
June 19, 2019 07:25 ET
|
Cure Pharmaceutical Holding Corp.
OXNARD, Calif. , June 19, 2019 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC: CURR), an innovative drug delivery and development company, today announced it is collaborating with Canopy Growth...